KALPALATHA GUNTUPALLI to Dose-Response Relationship, Drug
This is a "connection" page, showing publications KALPALATHA GUNTUPALLI has written about Dose-Response Relationship, Drug.
Connection Strength
0.181
-
Challenges in providing critical care for patients with anti-N-methyl-D-aspartate receptor encephalitis. Chest. 2014 May; 145(5):1143-1147.
Score: 0.085
-
A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med. 2013 Mar; 41(3):706-16.
Score: 0.078
-
Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med. 2004 Jan; 32(1):13-20.
Score: 0.010
-
An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med. 1999 May; 27(5):913-22.
Score: 0.007